Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug – Bloomberg Law News

… by Dexcel Pharma Technologies Ltd. infringes three patents for the blockbuster heart drug, an increasingly important source of Pfizer’s revenue.